Page last updated: 2024-11-13

sodium diatrizoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

histopaque: used for separating mononuclear & other cells [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sodium amidotrizoate : The sodium salt of a benzoic acid having iodo substituents at the 2-, 4- and 6-positions and acetamido substituents at the 3- and 5-positions. It is used, often as a mixture with the meglumine salt, as an X-ray contrast medium in gastrointestinal studies, angiography, and urography. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID23672589
CHEMBL ID1200581
CHEBI ID53692
SCHEMBL ID37116
MeSH IDM0006220

Synonyms (117)

Synonym
nsc-61815
sodium 3,5-bis(acetylamino)-2,4,6-triiodobenzoate
renografin 76 injectable (veterinary)
urovist sodium 300
3,5-diacetamido-2,4,6-triiodobenzoic acid, sodium salt
histopaque
hypaque cysto
3,5-diacetylamino-2,4,6-trijodbenzosaeure natrium [german]
benzoic acid, 3,5-diacetamido-2,4,6-triiodo-, sodium salt
sodium diacetyldiaminetriiodobenzoate
monosodium 3,5-diacetamido-2,4,6-triiodobenzoate
amidotrizoato sodico [inn-spanish]
natrii amidotrizoas [inn-latin]
nsc 61815
amidotrizoate de sodium [inn-french]
md 50
einecs 212-004-1
sodium diatrizoate
conray 35
diatrizoate sodium
diatrizoic acid sodium salt
hypaque sodium
triombrine
benzoic acid, 3,5-bis(acetylamino)-2,4,6-triiodo-, monosodium salt
benzoic acid, 3,5-diacetamido-2,4,6-triiodo-, monosodium salt
737-31-5
sodium 3,5-diacetamido-2,4,6-triiodobenzoate
sodium amidotrizoate
md-50
urovist sodium (tn)
sodium amidotrizoate (inn)
diatrizoate sodium (usp)
D01013
MLS000069526 ,
smr000058586
hypaque sodium 20%
urographing 370
CHEMBL1200581
CHEBI:53692 ,
amidotrizoato sodico
amidotrizoate de sodium
natrii amidotrizoas
hpaque - cysto
urovist sodium
3,5-diacetylamino-2,4,6-trijodbenzosaeure natrium
diatrizoate, sodium
radioselectan
dtxcid102912
dtxsid7022912 ,
cas-737-31-5
tox21_301439
NCGC00255327-01
v5403h8vg7 ,
diatrizoate sodium [usp]
urovist 300
sodium amidotrizoate [inn]
hsdb 8078
unii-v5403h8vg7
sodium diatrizoate [ban]
FT-0603095
angiovist component diatrizoate sodium
renocal component diatrizoate sodium
diatrizoate sodium component of renovist
sodium amidotrizoate [who-ip]
md-gastroview component diatrizoate sodium
diatrizoate sodium [orange book]
gastrovist component diatrizoate sodium
sodium amidotrizoate [who-dd]
diatrizoate sodium [usp monograph]
renografin component diatrizoate sodium
renovist component diatrizoate sodium
sodium amidotrizoate [ep monograph]
natrii amidotrizoas [who-ip latin]
diatrizoate sodium component of renografin
diatrizoate sodium [green book]
diatrizoate sodium component of renocal
sodium amidotrizoate [mart.]
diatrizoate sodium component of gastrovist
diatrizoic acid sodium salt [mi]
diatrizoate sodium component of angiovist
diatrizoate sodium [vandf]
24360-64-3
diatrizoate sodium component of gastrografin
diatrizoate sodium component of md-gastroview
diatrizoate sodium [who-ip]
sodium amidotrizoate [ep impurity]
gastrografin component diatrizoate sodium
SCHEMBL37116
ZEYOIOAKZLALAP-UHFFFAOYSA-M
AKOS024371067
OPERA_ID_214
c11h8i3n2nao4
sodium amidotrizoate; sodium 3,5-bis(acetylamino)-2,4,6-tri-iodobenzoate
CS-0013563
HY-B0926A
3,5-diacetamido-2,4,6-tiiodobenzoic acid sodium salt
diatrizoic acid sodium salt dihydrate
Q27104811
diatrizoic acid sodium salt;sodium amidotrizoate
CCG-270302
D97593
sodium;3,5-diacetamido-2,4,6-triiodobenzoate
sodium3,5-diacetamido-2,4,6-triiodobenzoate
hpaque-cysto
amidotrizoate de sodium (inn-french)
natrii diatrizoas
natrii amidotrizoas (inn-latin)
amidotrizoato de sodio
sodium amidotrizoate (mart.)
diatrizoate sodium (usp monograph)
sodio amidotrizoato
sodium amidotrizoate (ep monograph)
amidotrizoato sodico (inn-spanish)
urografic acid sodium salt
acidum diatrizoicum
sodium amidotrizoate (ep impurity)
meglumini diatrizoas
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
radioopaque mediumA substance having the property of absorbing, and therefore being opaque to, electromagnetic radiation, particularly X-rays.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
organoiodine compoundAn organoiodine compound is a compound containing at least one carbon-iodine bond.
organic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.04470.003245.467312,589.2998AID2517
Chain A, Beta-lactamaseEscherichia coli K-12Potency39.81070.044717.8581100.0000AID485294
pregnane X nuclear receptorHomo sapiens (human)Potency24.33650.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency48.55770.000229.305416,493.5996AID743079
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency5.01190.035520.977089.1251AID504332
lamin isoform A-delta10Homo sapiens (human)Potency0.00450.891312.067628.1838AID1487
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (15)

Assay IDTitleYearJournalArticle
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.67)18.7374
1990's2 (13.33)18.2507
2000's5 (33.33)29.6817
2010's7 (46.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.33 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index57.46 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]